Avadel Pharmaceuticals Plc ADR (AVDL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2004 | 03-2004 | 12-2003 | 09-2003 | 06-2003 | |
| Sales | 8,991 | 14,353 | 11,433 | 5,366 | 4,999 |
| Cost of Goods | 870 | 830 | 990 | 880 | 710 |
| Gross Profit | 8,110 | 13,510 | 10,300 | 4,480 | 4,280 |
| Operating Expenses | 11,050 | 10,560 | 9,860 | 7,330 | 6,730 |
| Operating Income | -2,059 | 3,793 | 1,573 | -1,964 | -1,731 |
| Interest Expense | 0 | 0 | 20 | 0 | 0 |
| Other Income | 509 | 527 | -393 | 104 | 111 |
| Pre-tax Income | -1,550 | 4,320 | 1,160 | -1,860 | -1,620 |
| Income Tax | 0 | 20 | -520 | 0 | 20 |
| Net Income Continuous | -1,941 | 4,297 | 1,862 | -1,869 | -1,650 |
| Net Income | $-1,941 | $4,297 | $1,862 | $-1,869 | $-1,650 |
| EPS Basic Total Ops | -0.07 | 0.20 | 0.09 | -0.11 | -0.10 |
| EPS Basic Continuous Ops | -0.09 | 0.20 | 0.09 | -0.10 | -0.10 |
| EPS Diluted Total Ops | -0.09 | 0.18 | 0.08 | -0.11 | -0.10 |
| EPS Diluted Continuous Ops | -0.09 | 0.18 | 0.08 | -0.10 | -0.10 |
| EBITDA(a) | $-1,699 | $4,393 | $2,053 | $-1,334 | $-1,581 |